Summary
The Latin America, Middle East and Africa Laser BPH Devices Market would witness market growth of 11.5% CAGR during the forecast period (2022-2028).
There are various options for BPH treatment. The patient and the doctor together decide on the best medicine. In mild cases no treatment is require at all. In some cases, minimally invasive procedures can be a favorable choice, and sometimes a combination of treatments works best. The main types of treatment for BPH are active surveillance, less invasive surgery, prescription drugs, and more invasive surgery.
A prostate laser surgery aids in reducing the urinary symptoms caused by BPH. During prostate laser surgery, a narrow fiber-optic scope is inserted in the patient’s urethra. The laser inserted through the scope cuts out or vaporizes the prostate tissue blocking the urine flow. According to the procedure, the doctor might also utilize instruments to remove the pieces of prostate tissue from the bladder.
In Saudi Arabia, the rate of diabetes has been estimated to be 9% to 22% from 1980 to 2008. The number of patients with diabetes is estimated to be around 7 million, while 3 million are in the prediabetic stage. Many factors are impacting this region’s prevalence, including unhealthy lifestyles, genetic susceptibility, and increased incidence of type 2 diabetic mellitus in children and young adults. The high prevalence of diabetes due to many factors is anticipated to surge the growth rate of people with prostate, which will surge the utilization of laser treatment for the BPH and propel the market growth in the LAMEA region.
The Brazil market dominated the LAMEA Laser BPH Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $13.3 Million by 2028. The Argentina market is experiencing a CAGR of 12.1% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 11.2% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on Procedure, the market is segmented into Photoselective Vaporization of Prostate and Holium Laser Ablation. Based on Type, the market is segmented into Holmium Laser, Thulium Laser, Green Light Laser and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.
Scope of the Study
Market Segments covered in the Report:
By End User
• Hospitals
• Clinics
• Others
By Procedure
• Photoselective Vaporization of Prostate
• Holium Laser Ablation
By Type
• Holmium Laser
• Thulium Laser
• Green Light Laser
• Others
By Country
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA
Companies Profiled
• Boston Scientific Corporation
• OmniGuide, Inc.
• Richard Wolf GmbH
• Coloplast Group
• Agiliti, Inc.
• HealthTronics, Inc. (Altaris Capital Partners, LLC)
• Endo International PLC
• Teleflex, Inc.
• Biolitec AG
• Metrum Cryoflex Sp. z o.o.
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
